Patient-controlled epidural analgesia after Caesarean section using meperidine

Purpose

To determine the effects of the addition of a background infusion to patient-controlled epidural analgesia (PCEA) using mependine for analgesia after Caesarean section.

Methods

In a randomized, double-blind study. we assigned 40 patients having elective Caesarean section to receive postoperative analgesia by patient-controlled epidural analgesia (PCEA) using mependme 5 mg · ml^?1 with (group Pi) or without (group Po) a background infusion of 10 mg · hr^?1. The PCEA settings (20 mg bolus. 10 mm lockout interval, four-hour maximum dose 150 mg) were otherwise identical. We compared pain at rest, pain on coughing, side effects, number of PCEA demands, drug consumption and patient satisfaction between groups in the first 24 hr after surgery.

Results

Total consumption of mependme was greater in group Pi (median 390 mg) than in group Po (median 240 mg; P = 0.017) and the number of PCEA demands was greater in group Po (median 12) than in group Pi (median 7.5;P = 0.012). Analgesia, side effects and patient satisfaction was similar between groups.

Conclusion

Addition of a background infusion to PCEA using mependine after Caesarean section has no clinical benefit.     

Patient-controlled epidural fentanyl following spinal fentanyl at Caesarean section

Spinal fentanyl can improve analgesia during Caesarean section. However, there is evidence that, following its relatively short-lived analgesic effect, there is a more prolonged spinal opioid tolerance effect. The effectiveness of postoperative epidural fentanyl analgesia may therefore be reduced following the use of spinal fentanyl at operation. This randomised, double-blind study was designed to assess whether patient-controlled epidural fentanyl could produce effective analgesia following 25 microg of spinal fentanyl at operation. Patients undergoing elective Caesarean section received spinal bupivacaine combined with either fentanyl 25 microg (fentanyl group; n = 18) or normal saline (saline group; n = 18). Patient-controlled epidural fentanyl was used for postoperative analgesia. The fentanyl group used a mean of 23.4 (SD 14.5) microg x h(-1) of fentanyl, compared with 27.0 (10.8) microg x h(-1) for the saline group (p =0.41). Using a 0-100 mm visual analogue score for pain, the maximum pain score recorded at rest for the fentanyl group was median 24 [IQR 15-35] mm, compared with 15 [13-45] mm for the saline group (p = 0.41). The maximum pain score recorded on coughing for the fentanyl group was 29 [24-46] mm, compared with 27 [19-47] mm for the saline group (p = 0.44). Nine of the fentanyl group rated postoperative analgesia as excellent and nine as good, compared with 10 of the saline group who rated it as excellent and eight as good (p = 0.74). Epidural fentanyl can produce effective analgesia following the use of 25 microg spinal fentanyl at Caesarean section.     

Postoperative intrathecal patient-controlled analgesia with bupivacaine, sufentanil or a mixture of both

In a randomised double-blind study, 45 patients, scheduled for major orthopaedic surgery under continuous spinal anaesthesia, received for relief of postoperative pain patient-controlled analgesia with either sufentanil 2 μgml⁻¹, bupivacaine 0.0625% or a mixture of both by the intrathecal route. The mean (SD) consumption of sufentanil and bupivacaine during the first 12 h was 65.5 (27.1) μg and 18.2 (4.8) mg, respectively. Combining bupivacaine and sufentanil reduced the consumption of both to ≈40% as compared to the administration of each component separately. Pain relief was very good in all subjects, although this was obtained faster with the combined regimen. Moreover, more patients in this group remained completely painfree during the entire observation period (p < 0.05). The incidence of hypotension was low and not significantly different when the plain bupivacaine group was compared with the two other groups. Nausea and vomiting were significantly more frequently observed in both groups treated with sufentanil. Motor block was not a major problem and was noticed during the first 2 h of treatment only. Tachyphylaxis did not occur. It was concluded that the groups receiving plain bupivacaine and sufentanil alone experienced pain relief of good quality. The use of a mixture, however, accelerated the onset of analgesia, improved the analgesic quality and reduced the doses for both components by 60% but at the expense of a higher incidence of nausea and vomiting.     

东莨菪碱-曲马多-芬太尼复合液用于剖宫产术后镇痛

目的观察静脉东莨菪碱配伍曲马多与芬太尼在剖宫产术后镇痛的临床效果及不良反应。方法ASAⅠ~Ⅱ级行剖宫产术病人60例,随机分为东莨菪碱组(S组)和氟哌利多组(D组),每组30例。S组,东莨菪碱0·3mg 曲马多500mg 芬太尼0·5mg;D组,氟哌利多2·5mg 曲马多500mg 芬太尼0·5mg。均以生理盐水配置100ml药袋,静脉给予负荷剂量4ml后连接镇痛泵进行病人自控镇痛(PCA)。术后24、48h行视觉模拟评分(VAS)和镇静评分,并对用药总量、PCA量及不良反应发生情况进行观察比较。结果两组VAS差异无显著意义。D组术后24h用药总量、PCA量和镇静评分均大于术后48h,D组术后24h镇静评分比S组高(P<0·05),不良反应发生率D组明显高于S组。结论东莨菪碱配伍曲马多及芬太尼应用于剖宫产术后镇痛安全有效,不良反应发生率明显低于氟哌利多。     

Plasma bupivacaine levels associated with extradural anaesthesia for Caesarean section

Plasma bupivacaine levels were measured in 47 women undergoing extradural Caesarean delivery. They were divided into four groups according to the following dose regimens using 0.5% bupivacaine. Group A were given a bolus of 20 ml with increment after 20 minutes. Groups B and C were given 10 ml initially with further increments if required at 10 minutes (group B) and 20 minutes (group C); Group D consisted of patients who had an extradural block extended for emergency Caesarean delivery. In the elective groups the highest and most rapidly achieved values were associated with group A and the lowest levels found in group C. The highest levels of all were found in the emergency group. The investigation indicates that slow controlled induction of extradural anaesthesia for Caesarean section greatly reduces the risk of local anaesthetic toxicity.     

剖宫产术后患者左旋布比卡因、罗哌卡因与布比卡因混合芬太尼硬膜外镇痛的效应

目的 比较左旋布比卡因、罗哌卡因和布比卡因复合芬太尼用于剖宫产术后硬膜外镇痛的效果和副作用。方法 采用随机双盲法,将51例择期行剖宫产术的足月、单胎孕妇分为三组:左旋布比卡因组(L组)、罗哌卡因组(R组)和布比卡因组(B组),每组17例。术后分别采用0.125％左旋布比卡因、0.2％罗哌卡因及0.125％布比卡因复合小剂量芬太尼(2μg·ml-1)行病人自控硬膜外镇痛(PCEA)。观察各组术后48 h内镇痛效果、运动阻滞程度变化以及恶心呕吐、尿潴留等副作用的发生率。结果 三组产妇术后视觉模拟评分、改良Bromage评分比较差异均无显著性(P>0.05)。三组产妇对PCEA的非常满意率差异无显著性(L组88.2％,R组76.5％,B组81.3％,P>0.05)。三组不良反应发生率及排气时间差异无显著性(P>0.05)。结论 0.125％左旋布比卡因混合芬太尼(2μg·ml-1)用于产科术后硬膜外镇痛可获得满意的镇痛效果且无明显毒副作用。     

Plasma concentrations of bupivacaine during extradural anaesthesia for Caesarean section

The clinical effects and plasma levels associated with the use of 0.5% bupivacaine with and without the addition of 1:200,000 adrenaline (5 micrograms/ml) were studied in 30 patients who underwent extradural anaesthesia for elective Caesarean section. The addition of adrenaline to bupivacaine prolongs analgesia, reduces the degree of hypotension and delays its onset. Plasma bupivacaine levels were consistently lower when adrenaline was added, but this difference was significant only at 10 minutes after the initial dose. Prolonging the interval between increments seems to be a more reliable way to reduce plasma concentration than the addition of the catecholamine.     

Patient-controlled epidural analgesia with bupivacaine and fentanyl suppresses postoperative delirium following hepatectomy

Postoperative delirium occurs frequently following major surgery, especially after hepatectomy. We hypothesized that better methods of postoperative pain control would decrease postoperative delirium. To clarify the magnitude of postoperative pain and incidence of postoperative delirium in hepatectomy patients, subjects received patient-controlled epidural analgesia (PCEA) using bupivacaine and fentanyl (Group P), or continuous epidural mepivacaine (Group E) following intraoperative epidural administration of morphine. The magnitude of postoperative pain was estimated by use of an analgesic adjuvant and delirium was classified as mild (insomnia, disturbance of sleepwake cycle), moderate (disorientation, hallucination), or severe (restlessness, confusion, agitation), based on the medical records. Analgesic adjuvant usage was less in Group P than in Group E, while the incidences of moderate and severe delirium were significantly less frequent in Group P than in Group E (35.7% versus 75.0%, and 14.3% versus 50.0% respectively). Moreover, less amount of antipsychotic drugs was given in Group P than in Group E. These results suggest that the better pain relief and patient satisfaction provided by PCEA contributed to a decrease in the incidence of delirium, because of continuous opioid administration and patient-control analgesia. We concluded that PCEA with bupivacaine and fentanyl can limit postoperative delirium following hepatectomy.     

A comparison between post-operative analgesia after intrathecal nalbuphine with bupivacaine and intrathecal fentanyl with bupivacaine after cesarean section

BackgroundAdding intrathecal opioids to intrathecal local anesthetics to decrease their doses and provide hemodynamic stability are major goals during spinal anesthesia in cesarean section. Different opioids were used to select the one with the longest duration of analgesia and the least side effects. In this study, intrathecal nalbuphine was compared with intrathecal fentanyl as an adjuvant to hyperbaric bupivacaine in cesarean section.Patients and methodsSixty female patients of ASA grades I and II presented for elective cesarean deliveries with spinal anesthesia were randomly allocated to 2 equal groups; Group F: 30 patients received intrathecal injection of 2 ml of 0.5% hyperbaric bupivacaine plus 0.5 ml fentanyl (25 μg); Group N: 30 patients received intrathecal injection of 2 ml of 0.5% hyperbaric bupivacaine plus 0.5 ml nalbuphine (0.8 mg). The onset of sensory and complete motor blockade, time of sensory blockade, duration of analgesia and motor blockade, fetal Apgar score, visual analog scale score, oxygen saturation, adverse effects and hemodynamic parameters were recorded intra-operatively and up to 4 h post-operatively. The effective analgesic time was recorded.ResultsThe onset of complete motor block was significantly more rapid in fentanyl group than in nalbuphine group. The duration of post-operative analgesia was more prolonged in nalbuphine group but the difference was insignificant. No significant difference was found between both groups as regards the duration of sensory block, motor block, duration of analgesia, fetal Apgar score, visual analog scale score, hemodynamic parameters and oxygen saturation. Adverse effects were less common in nalbuphine group but the difference was insignificant.ConclusionEither intrathecal nalbuphine 0.8 mg or intrathecal fentanyl 25 μg combined with 10 mg bupivacaine provides good intra-operative and early post-operative analgesia in cesarean section.     

Sympathetic blockade during extradural analgesia with mepivacaine or bupivacaine

The extent of sympathetic blockade in 36 patients, who had been given extradural analgesia, was studied by means of the skin conductance response (SCR). The SCR was also studied in six healthy volunteers who received, in a cross-over fashion, infusions of physiological saline (placebo) and saline containing mepivacaine. Two more volunteers were given saline containing bupivacaine. Extradural analgesia caused a partial blockade of sympathetic activity. The higher the level of analgesia the greater the degree of inhibition of the SCR. Complete blockade of the SCR or only a weak response in the foot was obtained in the majority of cases when the level of analgesia reached a dermatome level of T4 or higher. There was no significant relationship between the degree of motor blockade of the lower extremities and the intensity of blockade of the SCR. Extradural injection of 2% mepivacaine had a greater effect on the SCR than did 0.5% bupivacaine. There was no indication that infusion of mepivacaine or bupivacaine in volunteers, whose blood levels were as high as or higher than those likely to be produced during extradural analgesia, affected the SCR.     

Epidural fentanyl and 0.5% bupivacaine for elective Caesarean section

Either 100 micrograms fentanyl or 2 ml saline was added to 0.5% bupivacaine administered epidurally for elective Caesarean section in 30 patients, in a double-blind randomised study. Bupivacaine 0.5% was administered until a complete sensory block was established extending to the 4th thoracic dermatome. One of the patients who received epidural fentanyl required intravenous alfentanil and Entonox and another, Entonox only briefly during surgery, compared with seven in the control group who required intravenous alfentanil and Entonox and one who required Entonox only. Postoperative analgesia was of longer duration in those who received epidural fentanyl (p less than 0.01). There were no deleterious effects on neonatal or maternal outcome.     

Motor block during patient-controlled epidural analgesia with ropivacaine or ropivacaine/fentanyl after intrathecal bupivacaine for caesarean section

We compared patient-controlled epidural analgesia (PCEA) withropivacaine alone or combined with fentanyl in terms of analgesicefficacy, motor weakness and side-effects in patients who hadreceived spinal anaesthesia for elective Caesarean section.ASA I patients received combined spinal–epiduralanaesthesia and were randomly assigned, in a double-blind study,into two groups after operation: group R (n=23) received PCEAropivacaine 0.1%, bolus 5 mg, lockout 15 min, 3 mg h^–1background infusion, and group RF (n=24) received PCEA 0.1%ropivacaine/fentanyl 2 µg ml^–1 at identicalsettings. Pain and satisfaction on a 100 mm visual analoguescale (VAS) and side-effects were noted. Incidence of motorweakness (Bromage grade 1 or higher) was 48% (11/23) at8 h in group R compared with 13% (3/24) in group RF (P=0.025). Painscores on movement were lower in group RF at 8 and 12 hand at rest at 6 and 8 h (P<0.05 for each comparison).Analgesic consumption was less in RF (P=0.041), but there wasno difference in time to first request for supplementary analgesia.Patient satisfaction with postoperative analgesia (mean (SD))was higher in RF (79 (23) vs 57 (29) mm, P=0.045).Caution should be exercised using ropivacaine PCEA after spinalbupivacaine for Caesarean section, because its reputed motor-sparingproperty may be unreliable. Br J Anaesth 2000; 85: 468–70 ^* Corresponding author: University Department of Anaesthesia,Leicester General Hospital, Leicester LE5 4PW, UK     

Patient supplemented epidural analgesia after major abdominal surgery with bupivacaine/fentanyl or ropivacaine/fentanyl

PURPOSE: To compare analgesic efficacy and occurrence of motor block and other side effects during patient supplemented epidural analgesia (PSEA) with either ropivacaine/fentanyl or bupivacaine/fentanyl mixtures. METHODS: In a prospective, randomized, double-blind study, 32 ASAI-III patients undergoing major abdominal surgery received an epidural catheter at the T8- T10, followed by integrated general epidural anesthesia. Postoperative epidural analgesia was provided using a patient controlled pump with either ropivacaine 0.2%/2 microg x ml(-1) fentanyl (group Ropivacaine, n = 16) or bupivacaine 0.125%/2 microg x ml(-1) fentanyl (group Bupivacaine, n = 16) [background infusion 4-6 ml x hr(-1), 1.5 ml Incremental Doses and 20 min lock out]. Verbal pain rating score, number of incremental doses, consumption of epidural analgesic solution and rescue analgesics, sedation (four-point scale), and pulse oximetry were recorded by a blind observer for 48 hr after surgery. RESULTS: No differences in pain relief, motor block, degree of sedation, pulse oximetry and other side effects were observed between the two groups. The number of incremental doses and the volume of analgesic solution infused epidurally were higher in patients receiving the bupivacaine/fentanyl mixture (10 [0-52] I.D. and 236 [204-340] ml) than in patients receiving the ropivacaine/fentanyl solution (5 [0-50] I.D. and 208 [148-260] ml) (P = 0.03 and P = 0.05, respectively). CONCLUSION: Using a ropivacaine 0.2%/2 microg x ml(-1) fentanyl mixture for patient supplemented epidural analgesia after major abdominal surgery provided similar successful pain relief as bupivacaine 0.125%/2 microg x ml(-1) fentanyl, but patients receiving bupivacaine/fentanyl requested more supplemental.     

Patient-controlled analgesia following caesarean section under general anaesthesia: a comparison of fentanyl with morphine

This prospective, randomised, double-blind study compared PCA fentanyl with PCA morphine for post-Caesarean section analgesia. Following a standardised general anaesthetic, 37 women were allocated to receive either fentanyl (n = 18) or morphine (n = 19). The PCA was commenced after the women had been made comfortable in the postanaesthetic recovery room with the appropriate opioid solution (mean dose required = fentanyl 375 μg or morphine 16 mg). Initial PCA settings were bolus 1 ml (fentanyl 25 μg or morphine 1 mg), lockout time ten minutes, and no background infusion. Both analgesic solutions provided effective analgesia for a mean of 37 hr with high levels of patient satisfaction, and there were no differences in VAS scores for pain and patient satisfaction, or for side effects (nausea, itch, and sleepiness) between fentanyl or morphine. However, more patients in the fentanyl group required supplementary boluses or alterations to the PCA settings (13/18 vs 4/19: P = 0.005), and one patient was removed from the study due to inadequate analgesia. We conclude that fentanyl is not recommended for routine PCA use following Caesarean section. Cette étude randomisée et à double aveugle compare la PCA au fentanyl avec la PCA à la morphine pour l’analgésie postcésarienne. Après une anesthésie générate standard, 37 femmes sont réparties pour recevoir soil du fentanyl (n = 18) soil de la morphine (n = 19). La PCA est debutée à la salle de réveil des que les patientes se sentent confortables sous une solution appropriée de morphinique (dose moyenne requise, fentanyl 375 μg ou morphine 16 mg). Le régime initial consiste en un bolus d’un ml (fentanyl 25 μg ou morphine 1 mg), un intervalle de sécurité de dix minutes, sans perfusion continue. Les deux solutions produisent une analgésie satisfaisante pour 37 h en moyenne avec un degré élevé de satisfaction pour la patiente, et on ne note pas de différence entre le fentanyl et la morphine pour l’évaluation de la douleur par EVA, le degré de satisfaction, et pour les effets secondaires (nausée, prurit et somnolence). Cependant, plus de patientes sous fentanyl ont eu besoin de bolus supplémentaires ou des modifications aux réglages de la PCA (13/18 vs 4/19; P = 0,005). Une patiente est exclue de l’étude pour raison d’insuffisance d’analgésie. En conclusion, nous ne recommandons pas la PCA au fentanyl après la césarienne.

---

Presented at the 1992 meeting of the Society for Obstetric Anesthesia and Perinatology (SOAP) in Charleston, South Carolina, USA.     

Diclofenac for analgesia after Caesarean section

The analgesic efficacy of a single intramuscular dose of 75 mg diclofenac given after elective Caesarean section was studied in 50 women in a double-blind randomised manner using a patient-controlled analgesia system. The mean 18 h papavaretum consumption of the placebo group was significantly greater (91.4 mg compared to 61.4 mg). Subjective experience of pain and observed sedation were significantly greater in the control group up to 6 h after operation.     

Extending low-dose epidural analgesia in labour for emergency Caesarean section - a comparison of levobupivacaine with or without fentanyl

Women in labour receiving epidural analgesia with 15 ml bupivacaine 0.1% and 2 microg.ml(-1) fentanyl followed by 10-15-ml top-ups as required, who needed Caesarean section, were randomly allocated to receive 20 ml levobupivacaine 0.5% over 3 min with either 75 microg fentanyl (1.5 ml) or 1.5 ml saline. Further top-ups or inhaled or intravenous supplementation were given for breakthrough pain. Time to onset (loss of cold sensation to T4 and touch sensation to T5 bilaterally), quality of analgesia and side-effects were recorded. The study was stopped after 112 patients had been randomly assigned, due to a unit protocol change, from midwife-administered top-ups to patient-controlled epidural analgesia. Data from 51 patients given fentanyl and 54 given saline were available for analysis. There were no significant differences in onset times or supplementation between the groups, but there was more intra-operative nausea/vomiting with fentanyl (53%) than with saline (18%; p = 0.004). We found no advantage of adding fentanyl to epidural levobupivacaine when extending epidural analgesia in women already receiving epidural fentanyl during labour and there was an increased incidence of intra-operative nausea and vomiting. Power analysis suggested the same conclusion even had the study proceeded to completion.     

Patient-controlled epidural analgesia after major urologic surgeries. A comparison of tramadol with or without bupivacaine

The efficiency and safety of patient-controlled epidural analgesia by using tramadol alone and combined with bupivacaine were investigated for postoperative pain treatment after major urological surgeries. For PCEA: in group I (n = 17) a loading dose of 20 mg tramadol with a continuous infusion of 1 mg/ml tramadol at a rate of 8 ml/h was given. In group II (n = 17), patients received an initial loading dose of 20 ml bupivacaine 0.125% and a supplemental continuous infusion of 8 ml/h. In group III (n = 17), a loading dose of 20 mg tramadol with 20 ml bupivacaine 0.125% were given and a supplemental infusion of 1 mg/ml tramadol in 20 ml bupivacaine 0.125% combination was begun with a rate of 8 ml/h. A demand epidural bolus dose of 5 ml with a lockout time of 30 min was also used in all patients. VAS for pain intensity, vital signs, sedation scale and side effects was monitored at 0, 15, 30 min and 1, 2, 3, 4, 8, 12, and 24 h of the postoperative period. Statistical significance was determined using Kruskal-Wallis, Fisher's exact, analysis of variance for repeated measurements and Tukey tests. The hemodynamic values and sedation scales were insignificantly different (p > 0.05). The adequate analgesia was provided in all patients. However VAS values were significantly lower in group III than in groups I and II at every measurement (p < 0.05). The incidence of side effects in all three groups was low (p > 0.05). In conclusion, we suggested that a combination of tramadol with bupivacaine can provide the most effective and safe postoperative analgesia with minimal risk for side effects.